Granite Bay Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History
Granite Bay Wealth Management, LLC
- $288 Million
- Q1 2025
A detailed history of Granite Bay Wealth Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Granite Bay Wealth Management, LLC holds 600 shares of VRTX stock, worth $263,190. This represents 0.1% of its overall portfolio holdings.
Number of Shares
600
Previous 904
33.63%
Holding current value
$263,190
Previous $364,000
20.05%
% of portfolio
0.1%
Previous 0.13%
Shares
11 transactions
Others Institutions Holding VRTX
# of Institutions
1,828Shares Held
233MCall Options Held
1.38MPut Options Held
1.08M-
Capital World Investors Los Angeles, CA28.5MShares$12.5 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$10.3 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.35 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.38 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.17 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $113B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...